Treatment effects on sphingosine-1-phosphate and its receptors in major depressive disorder: implications for biomarkers

This publication has 55 references indexed in Scilit:

• Sphingosine-1-phosphate receptor 3 activation promotes sociability and regulates transcripts important for anxiolytic-like behavior
  Brain, Behavior, and Immunity, 2024
• Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress
  Pflügers Archiv - European Journal of Physiology, 2024
• Spatiotemporal sphingosine-1-phosphate receptor 3 expression within the cerebral vasculature after ischemic stroke
  iScience, 2024
• Sphingosine-1-phosphate Attenuates Endoplasmic Reticulum Stress-induced Cardiomyocyte Apoptosis Through Sphingosine-1-phosphate Receptor 1
  Archives of Medical Research, 2022
• Neuronal contact upregulates astrocytic sphingosine‐1‐phosphate receptor 1 to coordinate astrocyte‐neuron cross communication
  Glia, 2021
• Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects
  Drugs, 2020
• Gender differences in the link between depressive symptoms and ex vivo inflammatory responses are associated with markers of endotoxemia
  Brain, Behavior, & Immunity - Health, 2020
• Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders
  Psychopharmacology, 2019
• Mechanisms of sphingosine 1-phosphate receptor signalling in cancer
  Cellular Signalling, 2017
• Blood-Based Biomarkers in Depression: Emerging Themes in Clinical Research
  Molecular Diagnosis & Therapy, 2014